Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Morel

Showing results (61-70 of 276) with videos related to

Pageof 28
Sort By:
Clinical and Experimental Immunology|February 17, 2019
Immune cell metabolism in autoimmunityX Teng, W Li, C Cornaby, et al.
Soins. Chirurgie (Paris, France : 1982)|December 1, 1993
[Quality of life in geriatric surgery]C Fantin, C Mortier, L Morel, et al.
Advances in Nephrology From the Necker Hospital|January 1, 1974
Renal insufficiency in lupus nephritisJ Boelaert, L Morel-Maroger, J P Méry
Springer Seminars in Immunopathology|January 1, 1982
Renal lesions in dysproteinemiasP Verroust, L Morel-Maroger, J L Preud'Homme
Environmental Science & Technology|January 27, 2012
Microbial degradation in soil microcosms of fuel oil hydrocarbons from drilling cuttingsC H Chaineau, J L Morel, J Oudot
British Journal of Pharmacology|May 1, 1996
Angiotensin II-activated Ca2+ entry-induced release of Ca2+ from intracellular stores in rat portal vein myocytesJ L Morel, N Macrez-Leprêtre, J Mironneau
Arthritis and Rheumatism|September 29, 1998
Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone miceC Mohan, L Morel, P Yang, et al.
The Biochemical Journal|May 16, 1998
125I-Labelled mapacalcine: a specific tool for a pharmacological approach to a receptor associated with a new calcium channel on mouse intestinal membranesP Vidalenc, J L Morel, J Mironneau, et al.
The Journal of Biological Chemistry|March 29, 2000
Requirement of ryanodine receptor subtypes 1 and 2 for Ca(2+)-induced Ca(2+) release in vascular myocytesF Coussin, N Macrez, J L Morel, et al.
La Nouvelle Presse Medicale|March 22, 1975
[Letter: Treatment of lupic nephropathies]G Richet, P h Méry G, L Morel-Maroger
Pageof 28

Showing results (61-70 of 276) with videos related to

Sort By:
Pageof 28
Clinical and Experimental Immunology|February 17, 2019
Immune cell metabolism in autoimmunityX Teng, W Li, C Cornaby, et al.
Soins. Chirurgie (Paris, France : 1982)|December 1, 1993
[Quality of life in geriatric surgery]C Fantin, C Mortier, L Morel, et al.
Advances in Nephrology From the Necker Hospital|January 1, 1974
Renal insufficiency in lupus nephritisJ Boelaert, L Morel-Maroger, J P Méry
Springer Seminars in Immunopathology|January 1, 1982
Renal lesions in dysproteinemiasP Verroust, L Morel-Maroger, J L Preud'Homme
Environmental Science & Technology|January 27, 2012
Microbial degradation in soil microcosms of fuel oil hydrocarbons from drilling cuttingsC H Chaineau, J L Morel, J Oudot
British Journal of Pharmacology|May 1, 1996
Angiotensin II-activated Ca2+ entry-induced release of Ca2+ from intracellular stores in rat portal vein myocytesJ L Morel, N Macrez-Leprêtre, J Mironneau
Arthritis and Rheumatism|September 29, 1998
Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone miceC Mohan, L Morel, P Yang, et al.
The Biochemical Journal|May 16, 1998
125I-Labelled mapacalcine: a specific tool for a pharmacological approach to a receptor associated with a new calcium channel on mouse intestinal membranesP Vidalenc, J L Morel, J Mironneau, et al.
The Journal of Biological Chemistry|March 29, 2000
Requirement of ryanodine receptor subtypes 1 and 2 for Ca(2+)-induced Ca(2+) release in vascular myocytesF Coussin, N Macrez, J L Morel, et al.
La Nouvelle Presse Medicale|March 22, 1975
[Letter: Treatment of lupic nephropathies]G Richet, P h Méry G, L Morel-Maroger
Pageof 28